Radius Health, Inc.
Radius Health, Inc. (Form: DEFA14A, Received: 04/20/2018 16:13:35)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.     )

 

Filed by the Registrant  

Filed by a Party other than the Registrant  

Check the appropriate box:

 

Preliminary Proxy Statement

 

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

 

 

Definitive Proxy Statement

 

 

Definitive Additional Materials

 

 

Soliciting Material Pursuant to §240.14a-12

RADIUS HEALTH, INC.

 

(Name of Registrant as Specified in its Charter)

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

 

No fee required.

 

 

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

(1)

Title of each class of securities to which transaction applies:

 

 

 

 

(2)

Aggregate number of securities to which transaction applies:

 

 

 

 

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

 

 

(4)

Proposed maximum aggregate value of transaction: 

 

 

 

 

(5)

Total fee paid:

 

 

 

 

 

Fee paid previously with preliminary materials:

 

 

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

 

 

 

(1)

Amount previously paid:

 

 

 

 

(2)

Form, Schedule or Registration Statement No.:

 

 

 

 

(3)

Filing Party:

 

 

 

 

(4)

Date Filed:

 

 

 

 

 

 

 


 

 


*** Exercise Your Right to Vote ***  Important Notice Regarding the Availability of Proxy Materials for the  Stockholder Meeting to Be Held on June 6, 2018.  B  A  R  C  O  D  E  Meeting Information  RADIUS HEALTH, INC.   Meeting Type: Annual Meeting  For holders as of: April 11, 2018  Date: June 6, 2018 Time: 10:00 AM EDT  Location:  Goodwin Procter LLP  100 Northern Avenue  17th Floor  Boston, MA 02210  1 OF 2   1-BROADRIDGEXXXXXXXXXXXXXXXXXXXXXXXXXX40  2-FINANCIAL SOLUTIONSXXXXXXXXXXXXXXXXXX40   3-ATTENTION:XXXXXXXXXXXXXXXXXXXXXXXXXX40  4-TEST PRINT  5-51 MERCEDES WAY  6-EDGEWOOD,   7-NY  8-11717  12   15   You are receiving this communication because you hold  shares in the company named above.   This is not a ballot. You cannot use this notice to vote these  shares. This communication presents only an overview of  the more complete proxy materials that are available to  you on the Internet. You may view the proxy materials  online at www.proxyvote.com or easily request a paper copy  (see reverse side).   We encourage you to access and review all of the important  information contained in the proxy materials before voting.  DO NOT OVERLAP  E45911-P03767  RADIUS HEALTH, INC.  950 WINTER ST.  WALTHAM, MA 02451  See the reverse side of this notice to obtain  proxy materials and voting instructions.  P99999-010  12  15  # OF #   V.1.1 - CONS  RICS - REG/BN

 


 

Before You Vote  How to Access the Proxy Materials  Proxy Materials Available to VIEW or RECEIVE:  NOTICE AND PROXY STATEMENT ANNUAL REPORT SHAREHOLDER LETTER  How to View Online:  Have the information that is printed in the box marked by the arrow (located on the  following page) and visit: www.proxyvote.com.  How to Request and Receive a PAPER or E-MAIL Copy:  If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for  requesting a copy. Please choose one of the following methods to make your request:      1) BY INTERNET: www.proxyvote.com   2) BY TELEPHONE: 1-800-579-1639   3) BY E-MAIL*: sendmaterial@proxyvote.com  * If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked  by the arrow (located on the following page) in the subject line.  .  XXXX XXXX XXXX XXXX  DO NOT OVERLAP  E45912-P03767  .  XXXX XXXX XXXX XXXX  Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment  advisor. Please make the request as instructed above on or before May 23, 2018 to facilitate timely delivery.  How To Vote  Please Choose One of the Following Voting Methods  Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the  possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any  special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.   Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.     Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.  P99999-020  12  15  # OF #   .  XXXX XXXX XXXX XXXX

 


 

Voting Items  The Board of Directors recommends you vote  "FOR" all the nominees listed in Proposal 1 and  "FOR" Proposals 2, 3, and 4.  1. Election of the following nominees as Class I  Directors:   1a. Jesper Høiland   1b. Owen Hughes   1c. Debasish Roychowdhury, M.D.  2. Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018.  3. Approve, on an advisory basis, the compensation of our named executive officers.  DO NOT OVERLAP  E45913-P03767  4. Approve our 2018 Stock Option and Incentive Plan.  NOTE: To transact such other business as may properly come before the Annual Meeting or any continuation, postponement, or adjournment thereof.  XXXXXXXXXXXXX  XXXXXXXXXXX  Cusip  P99999-020  12  15  # OF #

 


 

0000000000  999999999999  02  NAME  THE COMPANY NAME INC. - COMMON 123,456,789,012.12345  THE COMPANY NAME INC. - CLASS A 123,456,789,012.12345  THE COMPANY NAME INC. - CLASS B 123,456,789,012.12345  THE COMPANY NAME INC. - CLASS C 123,456,789,012.12345  THE COMPANY NAME INC. - CLASS D 123,456,789,012.12345  THE COMPANY NAME INC. - CLASS E 123,456,789,012.12345  THE COMPANY NAME INC. - CLASS F 123,456,789,012.12345  THE COMPANY NAME INC. - 401 K 123,456,789,012.12345  DO NOT OVERLAP  E45914-P03767  XXXXXXXXXXXXX  XXXXXXXXXXX  Cusip  P99999-020  12  15  # OF #